Tymosine (immune injection)

1) Efficacy, effect

Adjuvant therapy for influenza vaccination in elderly patients with weakened immune function

2) Usage, dosage

Inject 900ug/㎡ (1 vial) of this drug subcutaneously or intramuscularly twice a week for 4 weeks starting from the first week of vaccination.
Immediately before administration, dissolve in the attached solvent and inject.

3) Packaging unit

2 vials/box

4) Ingredients, content

Cymosin alpha 1 1.6mg

5) Period of use

36 months from date of manufacture

6) Storage method

Sealed container, stored away from light, stored at 2~8°C